Table 3 The fold-difference between ZA-treated group normalized target and control group normalized target

CD31

 Fold^a

1.02 ± 0.21

1.15 ± 0.79

0.69 ± 0.40

2.39 ± 1.13

1.32 ± 0.97

2.40 ± 0.67

 p

0.880

0.770

0.270

0.230

0.590

0.048

VEGFA

 Fold

0.99 ± 0.15

1.28 ± 0.61

1.12 ± 0.43

1.45 ± 0.18

1.33 ± 0.30

0.41 ± 0.10

 p

0.120

0.820

0.016

1.000

0.060

0.029

VEGFR-2

 Fold

1.38 ± 0.24

0.87 ± 0.42

1.37 ± 0.54

1.19 ± 0.10

1.43 ± 0.54

0.73 ± 0.14

 p

0.480

0.400

0.069

0.082

0.040

0.039